Streetbeat News

CXXIF

C21 Investments Inc

Employees

135

Industry

Medicinal and Botanical Manufacturing

Open

0.19

Mkt cap

23M

Volume

15K

High

0.20

P/E Ratio

-6.43

52-wk high

0.47

Low

0.19

Div yield

N/A

52-wk low

0.15

C21 Investments Inc. reported a net loss and a slight revenue increase for Q1 2024, with Nevada sales declining by 1%. The company faced inflationary pressures and internal inventory issues but expects improved margins in the second half of the year. The launch of a new dispensary and a recent acquisition are expected to drive future growth.

Portfolio Pulse from Nina Zdinjak

August 16, 2024 | 2:51 pm

On August 15, 2024, several cannabis stocks experienced significant price movements. Notable gainers included Leafbuyer Techs, CLS Holdings USA, and Kaya Holdings, while Australis Capital and Greenlane Holdings were among the biggest losers.

Portfolio Pulse from Benzinga Insights

August 15, 2024 | 8:30 pm

Cannabis stocks showed significant movement on August 13, 2024, with notable gainers including Psychemedics (NASDAQ:PMD), OrganiGram Holdings (NASDAQ:OGI), SNDL (NASDAQ:SNDL), Village Farms Intl (NASDAQ:VFF), GrowGeneration (NASDAQ:GRWG), Canopy Growth (NASDAQ:CGC), and Tilray Brands (NASDAQ:TLRY). On the losing side, Greenlane Holdings (NASDAQ:GNLN) and Mexco Energy (AMEX:MXC) experienced declines.

Portfolio Pulse from Benzinga Insights

August 13, 2024 | 8:30 pm

On August 12, 2024, several cannabis stocks experienced significant price movements. Greenlane Holdings (NASDAQ:GNLN) saw a massive increase of 316.84%, closing at $11.50. Other notable gainers included Psychemedics (NASDAQ:PMD) and Genetic Technologies (NASDAQ:GENE). On the losing side, Global Hemp Group (OTC:GBHPF) dropped 53.79%, and cbdMD (AMEX:YCBD) fell 17.18%.

Portfolio Pulse from Benzinga Insights

August 12, 2024 | 8:30 pm

On August 8, 2024, several cannabis-related stocks experienced significant price movements. Notable gainers included CordovaCann, iAnthus Capital Holdings, Psychemedics, Aurora Cannabis, and Corbus Pharmaceuticals. Conversely, Greenlane Holdings and SOL Global Investments were among the notable losers.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 8:30 pm

On August 6, 2024, several marijuana stocks experienced significant price movements. Notable gainers included Elixinol Wellness, AusCann Group Holdings, and CNBX Pharmaceuticals, while Leafbuyer Techs and RIV Capital were among the biggest losers. The article highlights the performance of various US-listed companies and OTC stocks in the marijuana sector.

Portfolio Pulse from Benzinga Insights

August 06, 2024 | 8:30 pm

On August 2, 2024, several marijuana stocks experienced significant price movements. Notable gainers included CordovaCann, CNBX Pharmaceuticals, Urban-gro, Zelira Therapeutics, Greenlane Holdings, Psychemedics, cbdMD, and others. Conversely, Elixinol Wellness, Affinor Growers, Pharmadrug, Kaya Holdings, 4Front Ventures, and several other stocks saw declines.

Portfolio Pulse from Benzinga Insights

August 02, 2024 | 8:30 pm

C21 Investments Inc. reported $4.5M in revenue for a two-month stub period ending March 31, 2024, following a $3.5M acquisition of Deep Roots Harvest. The company maintained positive free cash flow and aligned its fiscal year end with industry peers.

Portfolio Pulse from Jelena Martinovic

August 02, 2024 | 1:41 pm

The article reports on the performance of various cannabis stocks on July 31, 2024. Notable gainers include Elixinol Wellness, AusCann Group Holdings, and Scotts Miracle Gro, while significant losers include Empower Clinics, Pharmadrug, and Psychemedics.

Portfolio Pulse from Benzinga Insights

July 31, 2024 | 8:30 pm

Cannabis stocks showed significant movement on July 30, 2024, with notable gainers including Elixinol Wellness, Pharmadrug, and Tilray Brands, while Maple Leaf Green World and CNBX Pharmaceuticals were among the biggest losers.

Portfolio Pulse from Benzinga Insights

July 30, 2024 | 8:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.